May 16, 2019
A key health ministry committee will discuss on May 28 whether to recommend a batch of new drugs including Alnylam Japan’s siRNA agent patisiran, known as Onpattro, for the treatment of hereditary transthyretin-mediated amyloidosis. If given the nod, they are...read more